Effects of COVID-19 vaccination on clinical outcomes in patients hospitalized in Internal Medicine during Omicron variant spreading
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Effects of COVID-19 vaccination on clinical outcomes in patients hospitalized in Internal Medicine during Omicron variant spreading ; volume:18 ; number:2 ; day:13 ; month:1 ; year:2023 ; pages:677-680 ; date:3.2023
Internal and emergency medicine ; 18, Heft 2 (13.1.2023), 677-680, 3.2023
- Urheber
-
Colangeli, Luca
Aprile, Gianna
Carcone, Clara
D’Adamo, Monica
Medda, Emanuela
Sbraccia, Paolo
Guglielmi, Valeria
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11739-022-03185-5
- URN
-
urn:nbn:de:101:1-2023080509052996113107
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Colangeli, Luca
- Aprile, Gianna
- Carcone, Clara
- D’Adamo, Monica
- Medda, Emanuela
- Sbraccia, Paolo
- Guglielmi, Valeria
- SpringerLink (Online service)
Ähnliche Objekte (12)
Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination
mRNA booster vaccination protects aged mice against the SARS-CoV-2 Omicron variant
Augmented neutralization of SARS‐CoV‐2 Omicron variant by boost vaccination and monoclonal antibodies
Assessing the COVID-19 vaccination program during the Omicron variant (B.1.1.529) epidemic in early 2022, Tokyo
Stability Analysis of B.1.1.529 SARS-Cov-2 Omicron Variant Mathematical Model: The Impacts Of Quarantine And Vaccination
Clinical characteristics and risk factors of severe COVID-19 in hospitalized neonates with omicron variant infection: a retrospective study
Africans’ response to the January 2023 Omicron variant wave in China: the impact of COVID-19 vaccination status
Limited cross-variant neutralization after primary Omicron infection: consideration for a variant-containing booster
Charge Matters: Mutations in Omicron Variant Favor Binding to Cells
Clinical characteristics and booster vaccine effectiveness of the Omicron variant
Heterotypic vaccination responses against SARS-CoV-2 Omicron BA.2
Disease Progression of Hospitalized Elderly Patients with Omicron BA.2 Treated with Molnupiravir
Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination
mRNA booster vaccination protects aged mice against the SARS-CoV-2 Omicron variant
Augmented neutralization of SARS‐CoV‐2 Omicron variant by boost vaccination and monoclonal antibodies
Assessing the COVID-19 vaccination program during the Omicron variant (B.1.1.529) epidemic in early 2022, Tokyo
Stability Analysis of B.1.1.529 SARS-Cov-2 Omicron Variant Mathematical Model: The Impacts Of Quarantine And Vaccination
Clinical characteristics and risk factors of severe COVID-19 in hospitalized neonates with omicron variant infection: a retrospective study
Africans’ response to the January 2023 Omicron variant wave in China: the impact of COVID-19 vaccination status
Limited cross-variant neutralization after primary Omicron infection: consideration for a variant-containing booster
Charge Matters: Mutations in Omicron Variant Favor Binding to Cells
Clinical characteristics and booster vaccine effectiveness of the Omicron variant
Heterotypic vaccination responses against SARS-CoV-2 Omicron BA.2
Disease Progression of Hospitalized Elderly Patients with Omicron BA.2 Treated with Molnupiravir
Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination
mRNA booster vaccination protects aged mice against the SARS-CoV-2 Omicron variant
Augmented neutralization of SARS‐CoV‐2 Omicron variant by boost vaccination and monoclonal antibodies
Assessing the COVID-19 vaccination program during the Omicron variant (B.1.1.529) epidemic in early 2022, Tokyo
Stability Analysis of B.1.1.529 SARS-Cov-2 Omicron Variant Mathematical Model: The Impacts Of Quarantine And Vaccination
Clinical characteristics and risk factors of severe COVID-19 in hospitalized neonates with omicron variant infection: a retrospective study
Africans’ response to the January 2023 Omicron variant wave in China: the impact of COVID-19 vaccination status
Limited cross-variant neutralization after primary Omicron infection: consideration for a variant-containing booster
Charge Matters: Mutations in Omicron Variant Favor Binding to Cells
Clinical characteristics and booster vaccine effectiveness of the Omicron variant
Heterotypic vaccination responses against SARS-CoV-2 Omicron BA.2